date:Feb 19, 2014
uable, profitable growth platforms. That is what we see in this whole extending the boundaries of health and wellness through Galderma.
The entry into skin health potentially takes Nestle into the realm of prescription-based medical solutions, but Mr. Bulcke said the company is not going to shy away from that aspect of the medical market.
There is indeed quite an important part of that business (Galderma) that is done by prescription, he said. We dont have a strategy that says we want to stay